Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis

Panagiotis Zis; Antonella Paladini; Alba Piroli; Patrick C McHugh; Giustino Varrassi; Marios Hadjivassiliou

doi:10.1007/s40122-017-0076-3

Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis

Panagiotis Zis, Antonella Paladini, Alba Piroli, Patrick C McHugh, Giustino Varrassi, Marios Hadjivassiliou

Research output: Contribution to journal › Review article › peer-review

34 Citations (Scopus)

Abstract

INTRODUCTION: Paraneoplastic neurological syndromes (PNS) consist of a heterogeneous group of neurological disorders triggered by cancer. The aim of this systematic review is to estimate the reported prevalence of pain in patients with paraneoplastic peripheral neuropathy (PPN).

METHODS: A systematic computer-based literature search was conducted on PubMed database.

RESULTS: Our search strategy resulted in the identification of 126 articles. After the eligibility assessment, 45 papers met the inclusion criteria. Full clinical and neurophysiological data were further extracted and involved 92 patients with PPN (54.5% males, mean age 60.0 ± 12.2 years). The commonest first manifestation of PPN is sensory loss (67.4%), followed by pain (41.3%), weakness (22.8%), and sensory ataxia (20.7%). In 13.0% of the cases, pain was the sole first manifestation of the PPN. During the course of the PPN, 57.6% of the patients may experience pain secondary to the neuropathy.

CONCLUSIONS: Pain is very prevalent within PPN. Pain specialists should be aware of this. Detailed history-taking, full clinical examination, and requesting nerve conduction studies might lead to an earlier diagnosis of an underlying malignancy.

Original language	English
Pages (from-to)	143-151
Number of pages	9
Journal	Pain and Therapy
Volume	6
Issue number	2
Early online date	1 Jul 2017
DOIs	https://doi.org/10.1007/s40122-017-0076-3
Publication status	Published - 1 Dec 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s40122-017-0076-3Licence: CC BY

Cite this

@article{e884552672c2457ebcaa13587316b84d,

title = "Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis",

abstract = "INTRODUCTION: Paraneoplastic neurological syndromes (PNS) consist of a heterogeneous group of neurological disorders triggered by cancer. The aim of this systematic review is to estimate the reported prevalence of pain in patients with paraneoplastic peripheral neuropathy (PPN).METHODS: A systematic computer-based literature search was conducted on PubMed database.RESULTS: Our search strategy resulted in the identification of 126 articles. After the eligibility assessment, 45 papers met the inclusion criteria. Full clinical and neurophysiological data were further extracted and involved 92 patients with PPN (54.5% males, mean age 60.0 ± 12.2 years). The commonest first manifestation of PPN is sensory loss (67.4%), followed by pain (41.3%), weakness (22.8%), and sensory ataxia (20.7%). In 13.0% of the cases, pain was the sole first manifestation of the PPN. During the course of the PPN, 57.6% of the patients may experience pain secondary to the neuropathy.CONCLUSIONS: Pain is very prevalent within PPN. Pain specialists should be aware of this. Detailed history-taking, full clinical examination, and requesting nerve conduction studies might lead to an earlier diagnosis of an underlying malignancy.",

keywords = "Cancer, Pain, Paraneoplastic, Polyneuropathy",

author = "Panagiotis Zis and Antonella Paladini and Alba Piroli and McHugh, {Patrick C} and Giustino Varrassi and Marios Hadjivassiliou",

year = "2017",

month = dec,

day = "1",

doi = "10.1007/s40122-017-0076-3",

language = "English",

volume = "6",

pages = "143--151",

journal = "Pain and Therapy",

issn = "2193-8237",

publisher = "Springer Healthcare",

number = "2",

}

TY - JOUR

T1 - Pain as a First Manifestation of Paraneoplastic Neuropathies

T2 - A Systematic Review and Meta-Analysis

AU - Zis, Panagiotis

AU - Paladini, Antonella

AU - Piroli, Alba

AU - McHugh, Patrick C

AU - Varrassi, Giustino

AU - Hadjivassiliou, Marios

PY - 2017/12/1

Y1 - 2017/12/1

N2 - INTRODUCTION: Paraneoplastic neurological syndromes (PNS) consist of a heterogeneous group of neurological disorders triggered by cancer. The aim of this systematic review is to estimate the reported prevalence of pain in patients with paraneoplastic peripheral neuropathy (PPN).METHODS: A systematic computer-based literature search was conducted on PubMed database.RESULTS: Our search strategy resulted in the identification of 126 articles. After the eligibility assessment, 45 papers met the inclusion criteria. Full clinical and neurophysiological data were further extracted and involved 92 patients with PPN (54.5% males, mean age 60.0 ± 12.2 years). The commonest first manifestation of PPN is sensory loss (67.4%), followed by pain (41.3%), weakness (22.8%), and sensory ataxia (20.7%). In 13.0% of the cases, pain was the sole first manifestation of the PPN. During the course of the PPN, 57.6% of the patients may experience pain secondary to the neuropathy.CONCLUSIONS: Pain is very prevalent within PPN. Pain specialists should be aware of this. Detailed history-taking, full clinical examination, and requesting nerve conduction studies might lead to an earlier diagnosis of an underlying malignancy.

AB - INTRODUCTION: Paraneoplastic neurological syndromes (PNS) consist of a heterogeneous group of neurological disorders triggered by cancer. The aim of this systematic review is to estimate the reported prevalence of pain in patients with paraneoplastic peripheral neuropathy (PPN).METHODS: A systematic computer-based literature search was conducted on PubMed database.RESULTS: Our search strategy resulted in the identification of 126 articles. After the eligibility assessment, 45 papers met the inclusion criteria. Full clinical and neurophysiological data were further extracted and involved 92 patients with PPN (54.5% males, mean age 60.0 ± 12.2 years). The commonest first manifestation of PPN is sensory loss (67.4%), followed by pain (41.3%), weakness (22.8%), and sensory ataxia (20.7%). In 13.0% of the cases, pain was the sole first manifestation of the PPN. During the course of the PPN, 57.6% of the patients may experience pain secondary to the neuropathy.CONCLUSIONS: Pain is very prevalent within PPN. Pain specialists should be aware of this. Detailed history-taking, full clinical examination, and requesting nerve conduction studies might lead to an earlier diagnosis of an underlying malignancy.

KW - Cancer

KW - Pain

KW - Paraneoplastic

KW - Polyneuropathy

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85042314015&origin=resultslist&sort=plf-f&src=s&sid=0a47b3f6b3521f1c05f23e2420ab7150&sot=b&sdt=b&sl=30&s=DOI%2810.1007%2fs40122-017-0076-3%29&relpos=0&citeCnt=25&searchTerm=

U2 - 10.1007/s40122-017-0076-3

DO - 10.1007/s40122-017-0076-3

M3 - Review article

C2 - 28669085

VL - 6

SP - 143

EP - 151

JO - Pain and Therapy

JF - Pain and Therapy

SN - 2193-8237

IS - 2

ER -

Pain as a First Manifestation of Paraneoplastic Neuropathies: A Systematic Review and Meta-Analysis

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this